178 related articles for article (PubMed ID: 37525448)
41. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF
Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630
[TBL] [Abstract][Full Text] [Related]
42. Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma.
Yanagi M; Hamasaki T; Akatsuka J; Endo Y; Takeda H; Kondo Y
BMC Urol; 2021 Dec; 21(1):167. PubMed ID: 34856960
[TBL] [Abstract][Full Text] [Related]
43. Early repeated ureteroscopy within 6-8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings.
Villa L; Cloutier J; Letendre J; Ploumidis A; Salonia A; Cornu JN; Montorsi F; Traxer O
World J Urol; 2016 Sep; 34(9):1201-6. PubMed ID: 26699629
[TBL] [Abstract][Full Text] [Related]
44. Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis.
Guo RQ; Hong P; Xiong GY; Zhang L; Fang D; Li XS; Zhang K; Zhou LQ
BJU Int; 2018 Feb; 121(2):184-193. PubMed ID: 29032580
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma is Independently Associated with Intravesical Recurrence after Radical Nephroureterectomy.
Liu P; Su XH; Xiong GY; Li XS; Zhou LQ
Int Braz J Urol; 2016; 42(6):1129-1135. PubMed ID: 27509369
[TBL] [Abstract][Full Text] [Related]
46. Grading of urothelial carcinoma of the upper urinary tract according to the World Health Organization/International Society of Urological Pathology classification from 2004 is a valuable tool when considering whether a patient is suitable for endoscopic treatment.
Almås B; Halvorsen OJ; Gjengstø P; Ulvik Ø; Beisland C
Scand J Urol; 2016 Aug; 50(4):298-304. PubMed ID: 26926878
[TBL] [Abstract][Full Text] [Related]
47. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma.
Favaretto RL; Shariat SF; Savage C; Godoy G; Chade DC; Kaag M; Bochner BH; Coleman J; Dalbagni G
BJU Int; 2012 Jan; 109(1):77-82. PubMed ID: 21631698
[TBL] [Abstract][Full Text] [Related]
48. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
[TBL] [Abstract][Full Text] [Related]
49. Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.
Metcalfe M; Wagenheim G; Xiao L; Papadopoulos J; Navai N; Davis JW; Karam JA; Kamat AM; Wood CG; Dinney CP; Matin SF
J Endourol; 2017 Sep; 31(9):946-953. PubMed ID: 28731777
[TBL] [Abstract][Full Text] [Related]
50. The efficacy and timing of adjuvant chemotherapy in upper tract urothelial carcinoma.
Li H; Zhou J; Chen R; Zhu J; Wang J; Wen R
Urol Oncol; 2023 Aug; 41(8):356.e1-356.e9. PubMed ID: 37331821
[TBL] [Abstract][Full Text] [Related]
51. Operative management in patients with upper tract urothelial carcinoma in Iceland: a population-based study.
Björnsson O; Jónsson E; Guðmundsson EO; Marteinsson VÞ; Nikulásson SÞ; Guðjónsson S
Scand J Urol; 2021 Jun; 55(3):197-202. PubMed ID: 33913379
[TBL] [Abstract][Full Text] [Related]
52. Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration).
Katims AB; Say R; Derweesh I; Uzzo R; Minervini A; Wu Z; Abdollah F; Sundaram C; Ferro M; Rha K; Mottrie A; Rosiello G; Simone G; Eun DD; Reese A; Kidd LC; Porter J; Bhattu AS; Gonzalgo ML; Margulis V; Marcus J; Danno A; Meagher M; Tellini R; Mari A; Veccia A; Ghoreifi A; Autorino R; Djaladat H; Mehrazin R
J Urol; 2021 Sep; 206(3):568-576. PubMed ID: 33881931
[TBL] [Abstract][Full Text] [Related]
53. Flexible fibre optic vs digital ureteroscopy and enhanced vs unenhanced imaging for diagnosis and treatment of upper tract urothelial carcinoma (UTUC): results from the Clinical Research Office of the Endourology Society (CROES)-UTUC registry.
Soria F; Laguna MP; Roupret M; Garcia-Marchinena P; Gonzalez MS; Habuchi T; Erkan E; Ng A; Gontero P; de la Rosette J
BJU Int; 2021 Dec; 128(6):734-743. PubMed ID: 34028166
[TBL] [Abstract][Full Text] [Related]
54. Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma.
Tsujino T; Komura K; Inamoto T; Maenosono R; Hashimoto T; Adachi T; Hirasawa Y; Tokushige S; Ohno T; Yamazaki S; Fukushima T; Nakamura K; Yano Y; Nishimura K; Kinoshita S; Nakamori K; Tsutsumi T; Matsunaga T; Yoshikawa Y; Uchimoto T; Takai T; Minami K; Uehara H; Hirano H; Nomi H; Takahara K; Ohno Y; Azuma H
World J Urol; 2023 Dec; 41(12):3585-3591. PubMed ID: 37924336
[TBL] [Abstract][Full Text] [Related]
55. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy.
Ouzzane A; Colin P; Ghoneim TP; Zerbib M; De La Taille A; Audenet F; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M
World J Urol; 2013 Feb; 31(1):189-97. PubMed ID: 23229227
[TBL] [Abstract][Full Text] [Related]
56. Histological variants and lymphovascular invasion in upper tract urothelial carcinoma can stratify prognosis after radical nephroureterectomy.
Takemoto K; Hayashi T; Hsi RS; Kobatake K; Sekino Y; Kitano H; Ikeda K; Goto K; Hieda K; Sentani K; Kajiwara M; Nishizaka T; Teishima J; Oue N; Hinata N
Urol Oncol; 2022 Dec; 40(12):539.e9-539.e16. PubMed ID: 36244916
[TBL] [Abstract][Full Text] [Related]
57. Comparison of oncological outcomes for hand-assisted and pure laparoscopic radical nephroureterectomy: results from the Taiwan Upper Tract Urothelial Cancer Collaboration Group.
Yu CC; Chen CH; Hong JH; Ke HL; Li WM; Chung SD; Wu WC; Chen YT; Jiang YH; Lin YH; Lin WY; Wu CC; Tsai YC
Surg Endosc; 2022 Jun; 36(6):4342-4348. PubMed ID: 34716480
[TBL] [Abstract][Full Text] [Related]
58. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
59. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
[TBL] [Abstract][Full Text] [Related]
60. Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study.
Foerster B; Abufaraj M; Matin SF; Azizi M; Gupta M; Li WM; Seisen T; Clinton T; Xylinas E; Mir MC; Schweitzer D; Mari A; Kimura S; Bandini M; Mathieu R; Ku JH; Marcq G; Guruli G; Grabbert M; Czech AK; Muilwijk T; Pycha A; D'Andrea D; Petros FG; Spiess PE; Bivalacqua T; Wu WJ; Rouprêt M; Krabbe LM; Hendricksen K; Egawa S; Briganti A; Moschini M; Graffeille V; Kassouf W; Autorino R; Heidenreich A; Chlosta P; Joniau S; Soria F; Pierorazio PM; Shariat SF
Eur Urol; 2021 Oct; 80(4):507-515. PubMed ID: 34023164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
